Strong commercial and technical progress for Pulsiv Solar
Portfolio company is working with a major multinational, engaged in discussions with others, and strengthened IP position
The Vaccine Group makes significant progress with COVID-19 animal vaccines
Portfolio company The Vaccine Group has made significant progress in developing animal vaccines based on its novel technology to tackle COVID-19.
The Vaccine Group starts work on COVID-19 animal vaccine
Move follows significant progress across several projects
The Vaccine Group starts work on COVID-19 animal vaccine, makes strong progress with technology
The Vaccine Group is today announcing it has made significant progress towards developing its novel vaccine platform technology
The Vaccine Group raises £680,000 through initial equity fund raise
The Vaccine Group (TVG) has raised £680,000 through its first equity funding round.